Profil
Luc Dochez is the founder of Pharvaris NV, founded in 2015, serving as Non-Executive Director.
Dr. Dochez is the founder of Vico Therapeutics BV, founded in 2019, serving as Chairman.
Current jobs include Chairman & Chief Executive Officer at Tusk Therapeutics SA since 2015; Executive Chairman, President & CEO at Hillstar Bio, Inc.; Executive Chairman at Montis Biosciences BV; Managing Director at Primix Bio Ventures BV; Managing Director at Premis BV; Director at Highlight Therapeutics SL; Director at QurAlis Corp.; Director at Volastra Therapeutics, Inc.; Director at Muna Therapeutics ApS; Director at Mahzi Therapeutics, Inc.; Director at Cascador Health BV since 2021; Director at Summation Bio, Inc.; and Managing Partner at Droia Ventures since 2018.
Former jobs include Chief Executive Officer at Tusk Therapeutics NV from 2015 to 2018; Chief Executive Officer & Director at Tusk Therapeutics Ltd. from 2015 to 2018; Independent Director at ERYTech Pharma SA from 2015 to 2023; Director-Business Development at Methexis Genomics NV; Director-Supervisory Board at Arcarios BV; Vice President-Business Development at TiGenix NV from 2003 to 2008; Consultant at Arthur D.
Little, Inc.; Chief Business Officer & SVP-Business Development at Prosensa Holding NV from 2010 to 2015; President at TiGenix, Inc.; Member-Supervisory Board at Ovizio Imaging Systems SA. Education includes graduate and doctorate degrees from Katholieke Universiteit Leuven and an MBA from Vlerick Leuven Gent Management School.
Postes actifs de Luc Dochez
| Sociétés | Poste | Début |
|---|---|---|
Primix Bio Ventures BV | Directeur Général | - |
Tusk Therapeutics SA
Tusk Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic products | Directeur Général | 01/03/2015 |
Premis BV | Directeur Général | - |
DROIA NV
DROIA NV Investment ManagersFinance Droia Ventures invests in companies located across the globe. The firm focuses on oncology and gentic disease related drug development companies. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01/10/2018 |
Highlight Therapeutics SL
Highlight Therapeutics SL BiotechnologyHealth Technology Develops immuno-oncology treatments for skin cancers | Directeur/Membre du Conseil | - |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Directeur/Membre du Conseil | - |
Montis Biosciences BV
Montis Biosciences BV BiotechnologyHealth Technology Develops immune-oncology therapeutics that targeting the intersection between vascular dysfunction and immune suppression to treat solid tumors | Président | - |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Fondateur | 01/01/2019 |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Luc Dochez
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Luc Dochez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlerick Leuven Gent Management School
Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
Methexis Genomics NV | |
TiGenix, Inc. | |
Arcarios BV
Arcarios BV Pharmaceuticals: MajorHealth Technology Discovers and develops innovative products for bone and joint diseases | Health Technology |
Ovizio Imaging Systems SA
Ovizio Imaging Systems SA Miscellaneous Commercial ServicesCommercial Services Develops cell counter based on holographic microscopy products | Commercial Services |
DROIA NV
DROIA NV Investment ManagersFinance Droia Ventures invests in companies located across the globe. The firm focuses on oncology and gentic disease related drug development companies. It provides financing for seed and early stage capital requirements. | Finance |
Primix Bio Ventures BV | |
Tusk Therapeutics NV
Tusk Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a research organization | Commercial Services |
Pharvaris NV
Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Tusk Therapeutics SA
Tusk Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic products | Health Technology |
Premis BV | |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Highlight Therapeutics SL
Highlight Therapeutics SL BiotechnologyHealth Technology Develops immuno-oncology treatments for skin cancers | Health Technology |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Health Technology |
Montis Biosciences BV
Montis Biosciences BV BiotechnologyHealth Technology Develops immune-oncology therapeutics that targeting the intersection between vascular dysfunction and immune suppression to treat solid tumors | Health Technology |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Health Technology |
Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Provides healthcare and biotechnology services | Health Technology |
Cascador Health BV
Cascador Health BV Packaged SoftwareTechnology Services Provides patient data management software for hospitals | Technology Services |
Summation Bio, Inc.
Summation Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a novel non-viral gene transfer technology | Commercial Services |
















